National Healthcare's Revenue in the fiscal year 2025 $ 1,517.78 millions
National Healthcare's Revenue in the fiscal year 2024 $ 1,307.38 millions
National Healthcare's Revenue in the fiscal year 2023 $ 1,141.54 millions
National Healthcare's Revenue in the fiscal year 2022 $ 1,085.74 millions
National Healthcare's Revenue in the fiscal year 2021 $ 1,074.30 millions
NHC Revenue second quarter 2026 Y/Y Growth Comment
National Healthcare Corp reported Revenue growth of 8.83% year on year in the second quarter 2026, to $ 408.03 millions, this is lower than National Healthcare Corp's recent average Revenue growth of 9.79%.
Looking into second quarter 2026 results within Healthcare Facilities industry 21 other companies have achieved higher Revenue growth. While National Healthcare Corp' s Revenue increase of 8.83% ranks overall at the positon no. 1955 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
National Healthcare's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
179.91 %
6.29 %
-100 %
(Mar 31 2018)
NHC's II. Quarter Q/Q Revenue Comment
National Healthcare Corp achieved in the II. Quarter 2026 above company average sequential Revenue increase of 6.86%, to $ 408.03 millions, from $381.82 millions in the first quarter. NHC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Healthcare Facilities industry 8 other companies have achieved higher Revenue quarter on quarter growth. While National Healthcare's Revenue growth quarter on quarter, overall rank is 1004.
National Healthcare Corp achieved in the II. Quarter 2026 above company average sequential Revenue increase of 6.86%, to $ 408.03 millions, from $381.82 millions in the first quarter. NHC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Healthcare Facilities industry 8 other companies have achieved higher Revenue quarter on quarter growth. While National Healthcare's Revenue growth quarter on quarter, overall rank is 1004.
National Healthcare's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 1,559.02
$ 1,525.91
$ 1,517.78
$ 1,500.62
$ 1,458.15
Y / Y Revenue Growth (TTM)
6.92 %
10.26 %
16.09 %
21.12 %
22.82 %
Year on Year Revenue Growth Overall
Ranking
# 918
# 496
# 609
# 453
# 1130
Seqeuential Revenue Change (TTM)
2.17 %
0.54 %
1.14 %
2.91 %
5.37 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 1955
# 1259
# 1251
# 862
# 1749
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, National Healthcare's cumulative twelve months Revenue were $ 1,559 millions, company would post below average annual Revenue growth of 5.37% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the National Healthcare's Revenue growth from the 381.82% growth in Mar 31 2026.
In the Healthcare sector 182 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 496 to 918.
With the quarterly Revenue reported in the Jun 30 2026 period, National Healthcare's cumulative twelve months Revenue were $ 1,559 millions, company would post below average annual Revenue growth of -111.01% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the National Healthcare's Revenue growth from the 381.82% growth in Mar 31 2026.
In the Healthcare sector 182 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 496 to 918.
About National Healthcare Revenue Growth Rates (NHC), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
15.35%